Real World Evidence Conference

Featured

Want to learn more about Real World Evidence Conference? You've come to the right site!

To keep you at the forefront.

Short Course:

Introduction to Real World Data for Data Geeks

Short Course:

Introduction to Real World Data for Data Geeks

Nancy A Dreyer, PhD, MPH, FISPE Founder
Dreyer Strategies LLC, United States
Steven A. Anderson, PhD Director, Office of Biostatistics and Epidemiology, CBER
FDA, United States
Dorothee Bartels, PhD, MSc Chief Digital Officer
Aetion, Germany
Brian Bradbury, DrSc, MA Vice President, Center for Observational Research
Amgen, United States
Paul M. Coplan, DrSc, MBA, MSc, FISPE VP, Medical Device Epidemiology & Real-World Data Analytics
Johnson & Johnson, United States
Marni Hall, PhD, MPH Vice President and General Manager, Global Regulatory Science and Strategy
IQVIA, United States
James Harnett, PharmD, MS Executive Director, Health Economics and Outcomes Research
Regeneron Pharmaceuticals, Inc. , United States
Jingyu (Julia) Luan, PhD Executive Regulatory Science Director, BioPharmaceuticals R&D
AstraZeneca, United States
David Martin, MD, MPH Vice President, Head, PCO Center of Excellence
Novartis, United States
Robert Reynolds, DrSc, MSc, FISPE Vice President, Epidemiology & Patient-Centered Outcomes, VEO
GSK, United States
Debra Schaumberg, DrSc, MPH Vice President and Global Head, Startegic Development Consulting Chair
Evidera | PPD, United States
Mark Stewart, PhD Vice President, Science Policy
Friends of Cancer Research, United States